Succinylcholine vs Rocuronium for Prehospital Emergency Intubation
NCT ID: NCT02000674
Last Updated: 2017-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1321 participants
INTERVENTIONAL
2013-12-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Comparisons studied will be : Intubation success rate at the first laryngoscopy, glottis exposure assessed by Cormack and Lehane classification, difficult intubation rate assessed by the Intubation Difficult Score (IDS), the conditions of intubation assessed by the Copenhagen score, the need for alternative airway techniques and the immediate post intubation complications rate as vomiting, dental trauma, pulmonary inhalation, arterial desaturation , hypotension episodes and cardiac arrest occurrence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Administration of Succinylcholine
Intubation after IV administration of Succinylcholine 1mg/kg
Succinylcholine : 1mg/kg
Administration of Rocuronium
Intubation after IV administration of Rocuronium 1.2 mg/kg
Rocuronium : 1.2 mg/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Succinylcholine : 1mg/kg
Rocuronium : 1.2 mg/kg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients under-18s;
* Patients under guardianship ;
* Pregnancy known;
* Patients with cons to one of the following three drugs: rocuronium, succinylcholine, sugammadex;
* Patients not affiliated to a social security scheme (beneficiary or legal).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unité de Soutien Méthodologique (CHU de La Réunion)
UNKNOWN
SAMU de Paris, Hôpital Necker - Enfants Malades
UNKNOWN
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xavier Combes, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de La Réunion
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de La Réunion
Saint-Denis, La Réunion, France
CHU de la Réunion
Saint-Pierre, La Réunion, France
CHU Avicenne
Bobigny, , France
CHU Henri Mondor
Créteil, , France
CHU de Dijon
Dijon, , France
CHU Raymond Poincaré
Garches, , France
CH Gonesse
Gonesse, , France
CHRU de Lille
Lille, , France
CH Marc Jacquet
Melun, , France
CHU de Nîmes
Nîmes, , France
CHU Hôtel-Dieu
Paris, , France
CHU Lariboisière
Paris, , France
CHU Necker
Paris, , France
CHU Pitié-Salpêtrière
Paris, , France
CH René Dubos
Pontoise, , France
CH Annecy
Pringy, , France
CHU Toulouse - Hôpital PURPAN
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guihard B, Chollet-Xemard C, Lakhnati P, Vivien B, Broche C, Savary D, Ricard-Hibon A, Marianne Dit Cassou PJ, Adnet F, Wiel E, Deutsch J, Tissier C, Loeb T, Bounes V, Rousseau E, Jabre P, Huiart L, Ferdynus C, Combes X. Effect of Rocuronium vs Succinylcholine on Endotracheal Intubation Success Rate Among Patients Undergoing Out-of-Hospital Rapid Sequence Intubation: A Randomized Clinical Trial. JAMA. 2019 Dec 17;322(23):2303-2312. doi: 10.1001/jama.2019.18254.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-001438-16
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
2013/CHU/05
Identifier Type: -
Identifier Source: org_study_id